J&J Appeals To Discard $2.5 M Risperdal Verdict
J&J Appeals To Discard $2.5 M Risperdal Verdict
Introduction
Risperdal manufacturer, Johnson & Johnson's unit, requested a Pennsylvania appeals court to discard a $2.5 million verdict against them. J&J asserted that the trial judge prevented the use of a scientific article to challenge an expert's opinion that Risperdal use leads to abnormal breast growth in young boys.
The verdict in question was the second-largest against Risperdal makers awarded to the plaintiff in February 2015. The plaintiff consumed the drug for a period of five years to treat autism-related behavioral issues. His parents claimed his abnormal breast growth was the result of Risperdal consumption.
Over 7,000 Risperdal product liability lawsuits against J&J are filed in the Pennsylvania State Court. Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).
Comments
Latest News
NC to Get $150M to Boost Opioid Treatment, Recovery
Categories: Opioids
North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…
SRI Gets FDA OK for High-Dose Naloxone Trial
Categories: Opioids
SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.
The approval was granted under an Investigational New Drug (IND)…
Spokane County to Get $5M in New Opioid Settlement
Categories: Opioids
Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.
The agreement addresses the company’s role in fueling…